Minerals Technologies
MTX · Specialty Chemicals
$62.90
1.8%Stepan
SCL · Specialty Chemicals
$63.91
0.6%The short version
- Stepan is the larger business, with $2.3B of revenue in fiscal 2025 against $2.1B for Minerals Technologies.
- Stepan grew revenue faster (7.0%, against −2.2%).
- Stepan kept more of each dollar of sales as operating profit (3.4% operating margin, against 2.3% operating margin).
- Minerals Technologies turned more of its sales into free cash flow (4.2% FCF margin, against 1.1% FCF margin).
- Stepan earned a higher return on the capital invested in it (3.6%, against 1.6%).
| Latest fiscal year | MTX · FY25 | SCL · FY25 |
|---|---|---|
| Size | ||
| Market cap | $2.0B | $1.5B |
| Revenue | $2.1B | $2.3B |
| Free cash flow | $86.6M | $25.4M |
| Net income | −$18.4M | $46.9M |
| Growth | ||
| Revenue growth | −2.2% | 7.0% |
| 5-year growth | 5.4% | 4.5% |
| Share count change | −2.8% | −0.2% |
| Profitability | ||
| Gross margin | 25.0% | 11.6% |
| Operating margin | 2.3% | 3.4% |
| Net margin | −0.9% | 2.0% |
| FCF margin | 4.2% | 1.1% |
| Return on capital | 1.6% | 3.6% |
| Return on equity | −1.1% | 3.9% |
| Balance sheet | ||
| Net debt | $629M | $494M |
| Net debt / EBITDA | — | 2.4x |
| Dividends and buybacks | $72.7M | $35.0M |
| Valuation & quality | ||
| P/E | — | — |
| Piotroski F-score | 4 | 6 |
FY16
MTX $1.6B
SCL $1.8B
FY17
MTX $1.7B
SCL $1.9B
FY18
MTX $1.8B
SCL $2.0B
FY19
MTX $1.8B
SCL $1.9B
FY20
MTX $1.6B
SCL $1.9B
FY21
MTX $1.9B
SCL $2.3B
FY22
MTX $2.1B
SCL $2.8B
FY23
MTX $2.2B
SCL $2.3B
FY24
MTX $2.1B
SCL $2.2B
FY25
MTX $2.1B
SCL $2.3B
MTX
SCL
FY16
MTX 13.7%
SCL 7.2%
FY17
MTX 14.6%
SCL 8.0%
FY18
MTX 14.2%
SCL 7.5%
FY19
MTX 11.7%
SCL 6.9%
FY20
MTX 11.8%
SCL 9.2%
FY21
MTX 12.7%
SCL 7.3%
FY22
MTX 10.1%
SCL 7.5%
FY23
MTX 7.9%
SCL 2.5%
FY24
MTX 13.5%
SCL 3.2%
FY25
MTX 2.3%
SCL 3.4%
MTX
SCL
FY16
MTX $163M
SCL $109M
FY17
MTX $131M
SCL $120M
FY18
MTX $128M
SCL $84.5M
FY19
MTX $173M
SCL $113M
FY20
MTX $174M
SCL $109M
FY21
MTX $146M
SCL −$122M
FY22
MTX $23.4M
SCL −$141M
FY23
MTX $140M
SCL −$85.5M
FY24
MTX $147M
SCL $39.3M
FY25
MTX $86.6M
SCL $25.4M
MTX
SCL
FY16
MTX 9.1%
SCL 13.3%
FY17
MTX 12.4%
SCL 14.2%
FY18
MTX 10.1%
SCL 15.6%
FY19
MTX 8.3%
SCL 13.2%
FY20
MTX 7.4%
SCL 15.6%
FY21
MTX 8.9%
SCL 12.9%
FY22
MTX 7.3%
SCL 11.3%
FY23
MTX 5.6%
SCL 2.9%
FY24
MTX 8.8%
SCL 3.4%
FY25
MTX 1.6%
SCL 3.6%
MTX
SCL
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.